Published in Epidemiol Infect on December 23, 2008
Infection with hepatitis B and C virus in Europe: a systematic review of prevalence and cost-effectiveness of screening. BMC Infect Dis (2013) 1.65
Occult hepatitis B virus infection among Egyptian blood donors. World J Hepatol (2013) 0.92
Hepatitis B virus burden in developing countries. World J Gastroenterol (2015) 0.91
Chronic hepatitis B in 2014: great therapeutic progress, large diagnostic deficit. World J Gastroenterol (2014) 0.83
Reducing the risk of hepatitis B virus transfusion-transmitted infection. J Blood Med (2011) 0.82
Hepatitis B and C virus reactivation in immunosuppressed patients with inflammatory bowel disease. World J Gastroenterol (2014) 0.81
Late HBsAg seroreversion of mutated hepatitis B virus after bone marrow transplantation. BMC Infect Dis (2013) 0.78
Opt-Out Panel Testing for HIV, Hepatitis B and Hepatitis C in an Urban Emergency Department: A Pilot Study. PLoS One (2016) 0.78
Substantial decline in hepatitis B virus infections following vaccine introduction in Tajikistan. Vaccine (2015) 0.78
Mutation spectrum of hepatocellular carcinoma from eastern-European patients betrays the impact of a complex exposome. J Expo Sci Environ Epidemiol (2014) 0.78
Vaccination coverage of children aged 12-23 months in Gaziantep, Turkey: comparative results of two studies carried out by lot quality technique: what changed after family medicine? BMC Public Health (2014) 0.75
What is the best way to manage screening for infections and vaccination of inflammatory bowel disease patients? World J Gastrointest Pharmacol Ther (2016) 0.75
The predictive value of transaminases at admission in patients hospitalized for heart failure: findings from the RO-AHFS registry. Eur Heart J Acute Cardiovasc Care (2013) 0.75
Assessment of Immunization to Hepatitis B Vaccine among Children under Five Years in Rural Areas of Taiz, Yemen. Hepat Res Treat (2017) 0.75
Update on entecavir in the management of severe forms of Hepatitis B. Hepat Med (2012) 0.75
Autism and measles, mumps, and rubella vaccine: no epidemiological evidence for a causal association. Lancet (1999) 11.10
The new measles campaign. BMJ (1994) 6.59
Severe respiratory illness caused by a novel coronavirus, in a patient transferred to the United Kingdom from the Middle East, September 2012. Euro Surveill (2012) 4.96
Willingness to pay for a quality-adjusted life year: in search of a standard. Med Decis Making (2000) 4.86
Relation of particle dimension to carcinogenicity in amphibole asbestoses and other fibrous minerals. J Natl Cancer Inst (1981) 4.60
Consequences of confirmed maternal rubella at successive stages of pregnancy. Lancet (1982) 4.56
Carcinogenicity of fibrous glass: pleural response in the rat in relation to fiber dimension. J Natl Cancer Inst (1977) 4.28
Impact of anti-vaccine movements on pertussis control: the untold story. Lancet (1998) 4.18
Improved site-directed mutagenesis method using PCR. Nucleic Acids Res (1991) 4.17
Salivary diagnosis of measles: a study of notified cases in the United Kingdom, 1991-3. BMJ (1994) 4.10
Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen. Lancet (1996) 4.05
A new method for active surveillance of adverse events from diphtheria/tetanus/pertussis and measles/mumps/rubella vaccines. Lancet (1995) 3.93
Cell migration inhibition factor released by antigen from human peripheral lymphocytes. Nature (1968) 3.62
Oral zinc in macular degeneration. Arch Ophthalmol (1988) 3.58
Transcriptional activation of an unrearranged and untranslocated c-myc oncogene by translocation of a C lambda locus in Burkitt. Proc Natl Acad Sci U S A (1983) 3.53
Serum HIV-1 RNA levels and time to development of AIDS in the Multicenter Hemophilia Cohort Study. JAMA (1996) 3.50
Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence. J Neurosci (2001) 3.46
Efficacy of meningococcal serogroup C conjugate vaccine in teenagers and toddlers in England. Lancet (2001) 3.19
SEX DIFFERENCES IN KIDNEY MORPHOLOGY AND CHLOROFORM NECROSIS. Science (1945) 3.18
Surveillance of antibody to measles, mumps, and rubella by age. BMJ (1988) 3.11
Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice. Demonstration of epitopes of oxidized low density lipoprotein in human plasma. J Clin Invest (1996) 3.10
Risk of vaccine failure after Haemophilus influenzae type b (Hib) combination vaccines with acellular pertussis. Lancet (2003) 3.10
Treatment of Early Mammary Carcinoma: A Cooperative International Study. Ann Surg (1963) 3.07
Transcatheter closure of patent foramen ovale after presumed paradoxical embolism. Circulation (1992) 3.04
Infection of the surgical site after arthroplasty of the hip. J Bone Joint Surg Br (2005) 2.94
Elevated maternal hemoglobin A1c in early pregnancy and major congenital anomalies in infants of diabetic mothers. N Engl J Med (1981) 2.89
Serological basis for use of meningococcal serogroup C conjugate vaccines in the United Kingdom: reevaluation of correlates of protection. Infect Immun (2001) 2.86
Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins. J Clin Invest (1999) 2.81
Congenital rubella in babies of south Asian women in England and Wales: an excess and its causes. Br Med J (Clin Res Ed) (1987) 2.81
Kaposi's-sarcoma-associated herpesvirus in HIV-negative Kaposi's sarcoma. Lancet (1995) 2.74
Case series analysis of adverse reactions to vaccines: a comparative evaluation. Am J Epidemiol (1996) 2.65
Carcinoembryonic antigen (CEA) assay. A laboratory adjunct in the diagnosis and management of cancer. Hum Pathol (1974) 2.57
Ability of 3 different meningococcal C conjugate vaccines to induce immunologic memory after a single dose in UK toddlers. J Infect Dis (2000) 2.57
High frequency of cross-reacting antibodies against 2009 pandemic influenza A(H1N1) virus among the elderly in Finland. Euro Surveill (2010) 2.56
Rubella vaccination in the UK: time for a complete strategy. Lancet (1985) 2.54
Supportive-expressive group therapy and distress in patients with metastatic breast cancer: a randomized clinical intervention trial. Arch Gen Psychiatry (2001) 2.51
Varicella-zoster virus epidemiology--a changing scene? J Infect Dis (1996) 2.48
Effect of selective vaccination on rubella susceptibility and infection in pregnancy. Br Med J (Clin Res Ed) (1985) 2.48
Fetal infection after maternal reinfection with rubella: criteria for defining reinfection. BMJ (1989) 2.48
Symptoms after primary immunisation with DTP and with DT vaccine. Lancet (1984) 2.48
Shift in age in chickenpox. Lancet (1993) 2.46
Mixing patterns and the spread of close-contact infectious diseases. Emerg Themes Epidemiol (2006) 2.45
Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis. Proc Natl Acad Sci U S A (1995) 2.44
Consequences of varicella and herpes zoster in pregnancy: prospective study of 1739 cases. Lancet (1994) 2.43
Update of Clostridium difficile infection due to PCR ribotype 027 in Europe, 2008. Euro Surveill (2008) 2.43
HIV-1 outbreak among injecting drug users in Greece, 2011: a preliminary report. Euro Surveill (2011) 2.42
Cell position and light influence C4 versus C3 patterns of photosynthetic gene expression in maize. EMBO J (1988) 2.37
Meningococcal C polysaccharide vaccine induces immunologic hyporesponsiveness in adults that is overcome by meningococcal C conjugate vaccine. J Infect Dis (2000) 2.35
Assessment of baseline age-specific antibody prevalence and incidence of infection to novel influenza A/H1N1 2009. Health Technol Assess (2010) 2.33
The epidemiology of measles in England and Wales: rationale for the 1994 national vaccination campaign. Commun Dis Rep CDR Rev (1994) 2.32
A longitudinal household study of Streptococcus pneumoniae nasopharyngeal carriage in a UK setting. Epidemiol Infect (2005) 2.32
Antibody avidity as a surrogate marker of successful priming by Haemophilus influenzae type b conjugate vaccines following infant immunization. J Infect Dis (1998) 2.26
Bordetella pertussis surveillance in England and Wales: 1995-7. Epidemiol Infect (1999) 2.24
Vitamin D status and health correlates among German adults. Eur J Clin Nutr (2007) 2.20
Meningococcal serogroup C conjugate vaccine is immunogenic in infancy and primes for memory. J Infect Dis (1999) 2.16
Varicella in maternity units. Lancet (1990) 2.16
Rubella susceptibility and the continuing risk of infection in pregnancy. Br Med J (Clin Res Ed) (1987) 2.13
The induction of immunologic memory after vaccination with Haemophilus influenzae type b conjugate and acellular pertussis-containing diphtheria, tetanus, and pertussis vaccine combination. J Infect Dis (1999) 2.04
Combined serum paraoxonase knockout/apolipoprotein E knockout mice exhibit increased lipoprotein oxidation and atherosclerosis. J Biol Chem (2000) 2.02
Possible environmental, occupational, and other etiologic factors for Parkinson's disease: a case-control study in Germany. Neurology (1996) 2.01
No evidence for measles, mumps, and rubella vaccine-associated inflammatory bowel disease or autism in a 14-year prospective study. Lancet (1998) 2.01
Seasonal influenza vaccine uptake in HSE-funded hospitals and nursing homes during the 2011/2012 influenza season. Ir Med J (2014) 2.00
Fat embolism prophylaxis with corticosteroids. A prospective study in high-risk patients. Ann Intern Med (1983) 1.99
Public perceptions in relation to intention to receive pandemic influenza vaccination in a random population sample: evidence from a cross-sectional telephone survey. Euro Surveill (2009) 1.98
Pandemic influenza A(H1N1) 2009 breakthrough infections and estimates of vaccine effectiveness in Germany 2009-2010. Euro Surveill (2010) 1.95
A cluster of invasive meningococcal disease in young men who have sex with men in Berlin, October 2012 to May 2013. Euro Surveill (2013) 1.93
Heterosexual co-transmission of hepatitis C virus (HCV) and human immunodeficiency virus (HIV). Ann Intern Med (1991) 1.91
Differences in national influenza vaccination policies across the European Union, Norway and Iceland 2008-2009. Euro Surveill (2010) 1.90
Interpretation of serological surveillance data for measles using mathematical models: implications for vaccine strategy. Epidemiol Infect (1995) 1.89
Pre-eclampsia and serum antibodies to oxidised low-density lipoprotein. Lancet (1994) 1.88
Increased autoantibody titers against epitopes of oxidized LDL in LDL receptor-deficient mice with increased atherosclerosis. Arterioscler Thromb Vasc Biol (1995) 1.88
The pre-vaccination epidemiology of measles, mumps and rubella in Europe: implications for modelling studies. Epidemiol Infect (2000) 1.86
Vasopressin in prevention of lumbar puncture headache. Br Med J (1968) 1.85
Changes in severity of 2009 pandemic A/H1N1 influenza in England: a Bayesian evidence synthesis. BMJ (2011) 1.85
Cloning of murine Stat6 and human Stat6, Stat proteins that are tyrosine phosphorylated in responses to IL-4 and IL-3 but are not required for mitogenesis. Mol Cell Biol (1995) 1.85
Effectiveness of seasonal 2010/11 and pandemic influenza A(H1N1)2009 vaccines in preventing influenza infection in the United Kingdom: mid-season analysis 2010/11. Euro Surveill (2011) 1.84
Pneumococcal bacteraemia and meningitis in England and Wales, 1993 to 1995. Commun Dis Public Health (1998) 1.80
The Support of Research in Medical and Allied Fields for the Period 1946 through 1951. Science (1952) 1.80
Macrophage-derived foam cells freshly isolated from rabbit atherosclerotic lesions degrade modified lipoproteins, promote oxidation of low-density lipoproteins, and contain oxidation-specific lipid-protein adducts. J Clin Invest (1991) 1.79
Investigation of the increased incidence of gonorrhoea diagnosed in genitourinary medicine clinics in England, 1994-6. Sex Transm Infect (2000) 1.78
Impact of meningococcal C conjugate vaccine in the UK. J Med Microbiol (2002) 1.77
A retrospective survey of clusters of meningococcal disease in England and Wales, 1993 to 1995: estimated risks of further cases in household and educational settings. Commun Dis Rep CDR Rev (1997) 1.76
Distinct T-cell subtypes induced with whole cell and acellular pertussis vaccines in children. Immunology (1998) 1.75
Phosphorylation and activation of the DNA binding activity of purified Stat1 by the Janus protein-tyrosine kinases and the epidermal growth factor receptor. J Biol Chem (1995) 1.72
Mortality caused by influenza and respiratory syncytial virus by age group in England and Wales 1999-2010. Influenza Other Respir Viruses (2012) 1.70
Increased blood pressure during potassium depletion in normotensive men. N Engl J Med (1989) 1.69
Influence of age on pain relief from analgesics. A study of postoperative patients. JAMA (1971) 1.68
Severity of whooping cough in England before and after the decline in pertussis immunisation. Arch Dis Child (1984) 1.67
Neisseria meningitidis group B correlates of protection and assay standardization--international meeting report Emory University, Atlanta, Georgia, United States, 16-17 March 2005. Vaccine (2006) 1.67
The comparative sero-epidemiology of varicella zoster virus in 11 countries in the European region. Vaccine (2007) 1.66
Antiphospholipid antibodies are directed against epitopes of oxidized phospholipids. Recognition of cardiolipin by monoclonal antibodies to epitopes of oxidized low density lipoprotein. J Clin Invest (1996) 1.65